Skip to main content
. 2021 May 20;46(1):134. doi: 10.3892/or.2021.8085

Figure 2.

Figure 2.

PCED1B-AS1 knockdown represses PDAC cell proliferation, invasion, and EMT. (A) RT-qPCR was utilized to investigate the expression of PCED1B-AS1 in CFPAC-1 and SW1990 cells transfected with si-NC or si-PCED1B-AS1. (B and C) CCK-8 and EdU staining assay were used to assess the effect of PCED1B-AS1 knockdown on proliferation of CFPAC-1 and SW1990 cells. (D) Transwell invasion assays were used to assess the effects of PCED1B-AS1 knockdown on the invasion of CFPAC-1 and SW1990 cells. (E) Western blotting was used to assess the expression of the EMT markers, E-cadherin, N-cadherin, Vimentin and Snail, following transfection. *P<0.05, **P<0.01, ***P<0.001 vs. si-NC. siRNA, small interfering RNA; si-NC, si-negative control; PDAC, pancreatic ductal adenocarcinoma; PCED1B-AS1, PC-esterase domain containing 1B-antisense RNA 1; RT-qPCR, reverse transcription-quantitative PCR; EMT, epithelial-mesenchymal transition; CCK-8, Cell Counting Kit-8.